Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-024353
Filing Date
2024-03-04
Accepted
2024-03-04 08:00:24
Documents
16
Period of Report
2024-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A amrn-20240304.htm   iXBRL DEF 14A 2656287
2 GRAPHIC img153232652_0.jpg GRAPHIC 7700
3 GRAPHIC img153232652_1.jpg GRAPHIC 39171
4 GRAPHIC img153232652_2.jpg GRAPHIC 34080
5 GRAPHIC img153232652_3.jpg GRAPHIC 33870
  Complete submission text file 0000950170-24-024353.txt   4178958

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20240304.xsd EX-101.SCH 39912
17 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20240304_htm.xml XML 384330
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21392 | Film No.: 24712878
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)